EUVIMEDEUVIMED entdecken
Crossref

A loss-function based approach for dose selection in two-stage dose-response trials

T Friede, M Kieser

Journal of Epidemiology and Biostatistics · 2001

DOI: 10.1080/13595220152601783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Epidemiology and Biostatistics, 2001. Verfasst von T Friede und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Statistics Unit, Lancaster University, UK. Hauptthemen laut MEDLINE: Dose-Response Relationship, Drug.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adaptive two-stage designs are a flexible tool in drug development and have the potential for an improvement of power over one-stage designs. In an adaptive two-stage dose-response trial, the dose-response relationship is examined in a preplanned interim analysis. If efficacy has not yet been proved, a subset of the most favourable doses may be selected for the second stage. This design offers the opportunity to combine dose selection and proof of efficacy within a single trial. METHODS: We consider a change-point regression model describing the dose-response relationship. In this framework, selection of the most favourable dose can be achieved by estimating the change point in the regression model. We introduce a change-point estimator that can be optimised by a loss-function based approach, taking into account both efficacy and safety aspects. We investigate the power characteristics of our approach. RESULTS: The proposed procedure performs well with regard to statistical power. The proposal demonstrates the feasibility of simultaneous modelling of efficacy and safety aspects by a loss-function based approach. CONCLUSION: Adaptive two-stage designs, in conjunction with an elaborated dose-selection rule, can support the decision about the suitable dose to use, leading to a considerable gain in power (or saving in sample size) and possibly speeding up the time-to-market in drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dose-Response Relationship, DrugClinical Trials as TopicDrug EvaluationEpidemiologic Research DesignHumansModels, StatisticalPharmacoepidemiologyRisk Assessment

Autor:innen und Institutionen

  • Medical Statistics Unit, Lancaster University, UK.

Zitieren

APA

Friede, T., & Kieser, M. (2001). A loss-function based approach for dose selection in two-stage dose-response trials. Journal of Epidemiology and Biostatistics. https://doi.org/10.1080/13595220152601783

Vancouver

Friede T, Kieser M. A loss-function based approach for dose selection in two-stage dose-response trials. Journal of Epidemiology and Biostatistics. 2001. doi:10.1080/13595220152601783

BibTeX
@article{Friede2001,
  author = {Friede, T and Kieser, M},
  title = {A loss-function based approach for dose selection in two-stage dose-response trials},
  journal = {Journal of Epidemiology and Biostatistics},
  year = {2001},
  doi = {10.1080/13595220152601783}
}
Kostenlos starten →